PETYAEV IVAN has a total of 16 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, United Kingdom and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are G2M CANCER DRUGS AG, XENON GENETICS INC and STELIC INSTITUTE REGENERATIVE MEDICINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | United Kingdom | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Agriculture | |
#6 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Analysing materials | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Foods | |
#6 | Special foods | |
#7 | Animal care | |
#8 | Microorganisms | |
#9 | Bakery products | |
#10 | Operating tables |
# | Name | Total Patents |
---|---|---|
#1 | Petyaev Ivan | 13 |
#2 | Pfeifer Andrea | 1 |
#3 | Zigangirova Nailya Akhatovna | 1 |
#4 | Bashmakov Yuriy | 1 |
#5 | Bash George | 1 |
#6 | Akhatovna Zigangirova Nailya | 1 |
Publication | Filing date | Title |
---|---|---|
US2012316249A1 | Lycopene for the treatment for metabolic dysfunction | |
US2010249023A1 | Isoflavone formulation | |
WO2007042827A2 | Treatment and diagnosis of obligate intracellular pathogens | |
GB0600244D0 | Treatment and diagnosis of pathogens | |
GB0521290D0 | Pathogen diagnosis | |
GB0421244D0 | Methods and means for the treatment of spongiform encephalopathy | |
GB0421243D0 | Spongiform encephalopathy treatment |